• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Careers
  • Blog
  • About
  • Services
  • Insights
  • Life Sciences
  • Contact
Hawkins Point Partners
Follow us on LinkedIn

Hawkins Point Partners

Life Sciences Consulting

  • About
  • Services
    • R&D blue iconResearch and Development

      • Optimizing IT and data management to help companies effectively and efficiently develop new therapies
    • IT quality blue iconIT Quality

      • Ensuring quality in the technology systems that support drug discovery, research, clinical, and commercial operations
    • commercial navy iconCommercial

      • Helping emerging and maturing Life Sciences companies solve the challenges associated with bringing therapies to market
    • enterprise blue iconEnterprise Services

      • Moving to the cloud to support core back office and operational processes that enable the organization
    • PPM blue iconProgram And Project Management

      • Leading highly visible and complex programs and projects
    • info management navy iconInformation Management and Analytics

      • Leveraging information assets and technologies to enable business
    • Close
  • Serving Life Sciences
  • Insights

Life Sciences

December 23, 2020 Sharlene Savino

Getting the Most Value From Your Vendor Relationships

Working Together Image | Hawkins Point Partners

Life Sciences companies often turn to vendors to help their teams implement initiatives around strategy, technology, and processes. The stakes can be high for these engagements, especially when they deal with core business operations. This makes it all the more important that your teams and your vendors communicate, collaborate, and work …

Read More

November 13, 2020 Bob Coopersmith

Examining the Value and Future of Drug Repurposing in Life Sciences

Life Science DNA | Hawkins Point Partners

In the Life Sciences industry, many drugs on the market today have been approved for indications for which they were not originally developed. Sometimes, discovering a new use for a drug happens by chance during a clinical trial or post-market, as more information is learned about the drug’s effects that weren’t originally …

Read More

October 27, 2020 John Morris

Being FAIR with Your Data Set-Up: The New Essential Practice for Life Science Companies to Extend the Value of their Science

metadata image | Hawkins Point Partners

There’s a growing understanding among smart life science organizations that their investments in their scientific data can’t be based on a one-and-done approach, where research data is set up for one goal, then discarded afterward. There’s too much future value in reusing the data for other important purposes. This is becoming especially …

Read More

Next Page »

Form CTA Band

Work With Us

  • This field is for validation purposes and should be left unchanged.

Bottom CTA Band

Top 10 Considerations for
a Product Launch

DOWNLOAD THE WHITEPAPER
Leadership Forum:
Disruptive Technologies Series
Learn More

Footer

978.455.4110

1 Technology Park Drive,
Suite 1, Westford, MA

Services

  • Research and Development
  • Commercial
  • IT Quality
  • Enterprise Services
  • Program and Project Management
  • Information Management and Analytics

About

  • Careers
  • Community
  • Blog
 

LIFE SCIENCES

INSIGHTS

BLOG

CAREERS

 
Copyright © 2021 Hawkins Point Partners Privacy Policy